| 영문 | medical record | 한글 | 의무기록 |
|---|---|---|---|
| 설명 | 의무기록은 법적으로 보호를 받게 되어 있으며, 특히 진료기록부와 수술기록부는 10년간 보존을 하도록 법에 명시되어 있다. 또한 법에 의한 경우가 아니고서는 타인에게 보여지지 않도록 되어 있다. 그러나, 환자의 진료를 위하여, 다른 의사의 요구가 있으면, 이를 보여주도록 되어 있다. |
||
| 영문 | medical examination | 한글 | 의학적 검사 |
|---|---|---|---|
| 설명 | 1. 건강의 유지와 증진, 병의 조기 발견이나 예방 따위를 위해서 심신의 상태를 검사하는 일. 2. 의사나 치과의사가 자각적-타각적으로 건강한 사람에 대하여 그 건강 상태를 진찰하는 일. 건강을 유지하기 위해서는 질병의 진단과 치료가 필요하지만, 치료에 있어서도 자각증상이나 타각증상이 있고 나서 손을 쓰다 보면 이미 때가 늦을 경우가 많으므로, 발병 초기에 조기진단을 함으로써 건강생활을 적극적으로 설계하려는 데에 의의가 있는 것이다. 건강진단을 크게 나누면, 개인적 건강유지를 위한 것과, 국민 전체의 건강유지를 위하여 행정적으로 특정한 대상자에게 의무적으로 하는 것이 있는데, 후자의 경우를 ‘정기건강진단’이라고 한다. 근로보건관리규정에는 위생상 유해한 직장의 종업원은 연2회 이상의 건강진단을 필요로 하고 있으며, 그 밖의 직장에서는 연1회 이상으로 규정하고 있다. 학교보건법에서는 매년 학생과 교직원의 신체검사를 하게 되어 있고, 결핵예방법에서는 모든 국민은 연1회 이상 결핵에 관한 건강진단을 받도록 되어 있으며, 모자보건법에서는 임신부와 영유아에 대한 건강진단을 규정하고 있다. 이 밖에 접객업소에서도 전염병-피부병에 관한 건강진단을 받아야 한다는 규정이 업종별로 정해져 있다. |
||
| 영문 | electronic medical record(EMR) | 한글 | 전자의무기록 |
|---|---|---|---|
| 설명 | 의사가 종이 대신 컴퓨터에 직접 환자의 임상정보를 입력하면 이를 데이터베이스화하여 새로운 정보로 가공-생성하는 의료정보시스템. 환자의 진료기록을 찾아 진료실에 전달하고 다시 처방전을 받아 조제하는 일련의 과정이 네트워크로 처리돼 환자대기시간이 대폭 줄고, 별도의 진료기록실이 불필요하다. |
||
| ART | absolute retention time; Accredited Record Technician; acoustic reflex test; algebraic reconstructio... |
|---|---|
| FTOL | "Failed" Trial Of Labor; when a woman tries for a VBAC and ends up with a cesarean after a "trial of... |
| QCIM | Quarterly Cumulative Index Medicus |
| EMT | emergency medical tag; emergency medical team; emergency medical technician; emergency medical treat... |
| CT | calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ... |
| ART | Algebraic Reconstruction Technique |
|---|---|
| CHART | Craig Handicap Assessment and Reporting Technique |
| DEFT | Direct Epifluorescent Filter Technique |
| EMIT | Enzyme Multiplied Immuno-assay Technique |
| FAT | Fluorescent antibody technique |
trial flask closure
triamterene
| Bernoulli trial | A single random event for which there are two and only two possible outcomes that are mutually exclusive and have a priori fixed (and complementary) probabilities of resulting. The trial is the realization of this process. Conventionally one outcome is termed a success and is assigned the score 1, the other is a failure and has the score zero. Thus the outcome might be 0 (no heads, one tail) or 1 (1 head, no tails). (05 Mar 2000) |
|---|---|
| randomised controlled trial | A clinical trial that involves at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Treatment allocations using coin flips, odd-even numbers, patient social security numbers, days of the week, medical record numbers, or other such pseudo- or quasi-random processes, are not truly randomised and a trial employing any of these techniques for patient assignment is designated simply a controlled clinical trial. (12 Dec 1998) |
| randomised trial | <statistics> A clinical trial in which patients have been randomly assigned to receive either the study drug or alternative treatment, in which neither the patient nor the physician conducting the study know which treatment is being given the patient, and in which the alternative to the study drug is a placebo, the study is conducted at several centres. (09 Oct 1997) |
| phase I clinical trial | <pharmacology> The earliest stage clinical trial for studying an experimental drug in humans. Phase I trials are generally comparatively small and are used to determine toxicity and maximum dose. They provide an initial evaluation of a drug's safety and pharmacokinetics-how the drug is absorbed, what tissues it reaches and how long it takes to leave the body. Such studies also usually test various doses of the drug (dose-ranging) to obtain an indication of the appropriate dose to use in later studies. The patients in these trials usually have advanced disease and have already received best available chemotherapy, therefore, seeing a repose is significant partially because this means there is a lack of cross-resistance between two anti-cancer drugs. (31 Dec 1997) |
| phase II clinical trial | <pharmacology> Usually focus on the activity of the new product as a single agent in a noncomparative, open study. (31 Dec 1997) |
| phase III clinical trial | <pharmacology> An advanced stage clinical trial that should conclusively show how well a drug works as compared to other treatments. Phase III trials are large, frequently multi-institution tests. They generally compare the relative value of the new drug compared with the current standard treatment and measure whether a new drug extends survival or otherwise improves the health of patients on treatment (clinical improvement) rather than just provide surrogate marker data. These studies generally last longer and are larger than phase II trials. (31 Dec 1997) |
| clinical trial | <pharmacology> Research study conducted with patients, usually to evaluate a new treatment or drug. Each trial is designed to answer scientific questions and to find better ways to treat individuals with a specific disease. (12 May 1997) |
| clinical trial, phase I | A pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques based on a small number of healthy persons and conducted over the period of about a year in either the united states or a foreign country. (12 Dec 1998) |
| clinical trial, phase II | A pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques based on several hundred volunteers, including a limited number of patients, and conducted over a period of about two years in either the united states or a foreign country. (12 Dec 1998) |
| clinical trial, phase III | A pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques after phase II trials. A large enough group of patients is studied and closely monitored by physicians for adverse response to long-term exposure, over a period of about three years in either the united states or a foreign country. (12 Dec 1998) |
| clinical trial, phase IV | Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale after clinical trials, phases I, II, and III. These studies, conducted in the united states or a foreign country, often garner additional data about the safety and efficacy of a product. (12 Dec 1998) |
| controlled clinical trial | A clinical trial involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicine, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trial is characterised as a randomised controlled trial. However, trials employing treatment allocation methods such as coin flips, odd-even numbers, patient social security numbers, days of the week, medical record numbers, or other such pseudo- or quasi-random processes are simply designated as controlled clinical trials. (12 Dec 1998) |
| controlled trial | A clinical study in which one group of participants receives an experimental drug while another group receives either a placebo or an approved standard therapy. When participants do not know which group they are in, the trial is blinded. See: Double-Blind. (09 Oct 1997) |
| prospective, randomised, double-blind clinical trial | <statistics> A clinical trial in which the method for analysing data has been specified in the protocol before the study has begun (prospective), the patients have been randomly assigned to receive either the study drug or alternative treatment, and in which neither the patient nor the physician conducting the study know which treatment is being given to the patient. (13 Nov 1997) |
| human clinical trial | <pharmacology> Controlled clinical studies in human volunteers to test the safety and efficacy of pharmaceutical candidates. There are usually three distinct phases of human clinical testing: Phases I, II, and III. Phase I trials are safety studies of volunteers, usually healthy controls. Phase II trials are studies to confirm safety and study optimum dose and initial efficacy. Phase III trials are studies to prove safety and efficacy in a specific patient population. (14 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|